Through the use of our unique drug delivery technology, LiquiXR®, Tris Pharma is pioneering strategies to attack a variety of diseases. Extending our successful track record of 8 approved NDAs, Tris Pharma’s rich pipeline of product candidates demonstrates our leadership in developing innovative drugs that meet otherwise unmet patient needs.
Tris Brand Pipeline Overview
ADHD, attention deficit hyperactivity disorder; CNS, central nervous system; NDA, new drug application.
Together, we can achieve more.